Is asparagine-linked protein glycosylation an obligatory requirement for angiogenesis?
dc.contributor.author | Banerjee, D K | en_US |
dc.contributor.author | Vendrell-Ramos, M | en_US |
dc.date.accessioned | 1993-12-01 | en_US |
dc.date.accessioned | 2009-05-27T09:26:28Z | |
dc.date.available | 1993-12-01 | en_US |
dc.date.available | 2009-05-27T09:26:28Z | |
dc.date.issued | 1993-12-01 | en_US |
dc.description.abstract | Dependence of protein N-glycosylation on capillary endothelial cell proliferation has been studied. Amphomycin, a potent N-glycosylation inhibitor, inhibited capillary endothelial cell proliferation in a dose-dependent manner. beta-Agonist isoproterenol as well as other intracellular cAMP enhancing agents, viz. cholera toxin, prostaglandin E1 and 8Br-cAMP, also enhanced capillary endothelial cell proliferation. In addition to cell proliferation, isoproterenol also enhanced protein glycosylation in these cells. Isoproterenol effect was mediated by beta-adrenoreceptors, as it got reduced on pre-treatment of cells with either atenolol or ICI 118, 551 or propranolol. Furthermore, isoproterenol stimulation of protein glycosylation by exogenous dolichyl monophosphate and its inhibition by tunicamycin (GlcNAc-1P transferase inhibitor) supported the concept that isoproterenol specifically stimulated protein N-glycosylation event(s) in the cell. | en_US |
dc.description.affiliation | Department of Biochemistry, School of Medicine, University of Puerto Rico, San Juan 00936-5067. | en_US |
dc.identifier.citation | Banerjee DK, Vendrell-Ramos M. Is asparagine-linked protein glycosylation an obligatory requirement for angiogenesis? Indian Journal of Biochemistry & Biophysics. 1993 Dec; 30(6): 389-94 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/27515 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://https://www.niscair.res.in/ScienceCommunication/ResearchJournals/rejour/ijbb/ijbb0.asp | en_US |
dc.subject.mesh | 8-Bromo Cyclic Adenosine Monophosphate --pharmacology | en_US |
dc.subject.mesh | Adrenal Medulla --cytology | en_US |
dc.subject.mesh | Adrenergic beta-Antagonists --pharmacology | en_US |
dc.subject.mesh | Alprostadil --pharmacology | en_US |
dc.subject.mesh | Animals | en_US |
dc.subject.mesh | Anti-Bacterial Agents --pharmacology | en_US |
dc.subject.mesh | Asparagine | en_US |
dc.subject.mesh | Cattle | en_US |
dc.subject.mesh | Cell Division --drug effects | en_US |
dc.subject.mesh | Cells, Cultured | en_US |
dc.subject.mesh | Cholera Toxin --pharmacology | en_US |
dc.subject.mesh | Cyclic AMP --metabolism | en_US |
dc.subject.mesh | Endothelium, Vascular --cytology | en_US |
dc.subject.mesh | Glycosylation --drug effects | en_US |
dc.subject.mesh | Isoproterenol --pharmacology | en_US |
dc.subject.mesh | Lipopeptides | en_US |
dc.subject.mesh | Neovascularization, Pathologic | en_US |
dc.subject.mesh | Oligopeptides --pharmacology | en_US |
dc.subject.mesh | Protein Processing, Post-Translational --drug effects | en_US |
dc.title | Is asparagine-linked protein glycosylation an obligatory requirement for angiogenesis? | en_US |
dc.type | Journal Article | en_US |
dc.type | Research Support, U.S. Gov't, P.H.S. | en_US |
Files
License bundle
1 - 1 of 1